Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery

Journal of Pharmaceutical Sciences

Volumn 102, Issue 6, 2013, Pages 1957-1969

  Yuan, Xudong ^a   Capomacchia, Anthony C ^b  

^a MONMOUTH UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Calorimetry (DSC); Enantiomer; Eutectic; Ibuprofen; Percutaneous; Permeability; Racemate; Transdermal; Transdermal drug delivery; X ray powder diffractometry

Indexed keywords

2 PROPANOL; IBUPROFEN;

AQUEOUS SOLUTION; ARTICLE; CHIRALITY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; EMULSION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIQUID; MATHEMATICAL MODEL; MELTING POINT; MEMBRANE TRANSPORT; PHYSICAL CHEMISTRY; RACEMIC MIXTURE; SKIN PERMEABILITY; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

EID: 84877926798     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23548     Document Type: Article

References (36)

1. Li ZJ, Grant DJ. 1997. Relationship between physical properties and crystal structures of chiral drugs. J Pharm Sci 86(10):1073-1078.
2. Millership JS, Fitzpatrick A. 1993. Commonly used chiral drugs: A survey. Chirality 5(8):573-576.
3. Nation RL. 1994. Chirality in new drug development. Clinical pharmacokinetic considerations. Clin Pharmacokinet 27(4):249-555.
4. Popa R. 1997. A sequential scenario for the origin of biological chirality. J Mol Evol 44(2):121-127.
5. Liu WM. 1982. Remarks on origins of biomolecular asymmetry. Orig Life 12(2):205-209.
6. Coutts RT, Baker GB. 1989. Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. Chirality 1(2):99-120.
7. Hutt AJ, Tan SC. 1996. Drug chirality and its clinical significance. Drugs 52 Suppl 5:1-12.
8. Crom WR. 1992. Effect of chirality on pharmacokinetics and pharmacodynamics. Am J Hosp Pharm 49(9 Suppl 1):S9-S14.
9. Heard CM, Brain KR. 1995. Does solute stereochemistry influence percutaneous penetration? Chirality 7(4):305-309.
10. Touitou E, Godin B, Kommuru TR, Afouna MI, Reddy IK. 2004. Transport of chiral molecules across skin. In Chirality in drug design and development; Reddy IK, Mehvar R, Eds. Marcel Dekker: New York, pp 6-101.
11. Valentova J, Bauerova K, Farah L, Devinsky F. 2010. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin? Arch Dermatol Res 302:635-638.
12. Alberti E, De Micheli C, Montanari L. 2010. Stereoselective percutaneous absorption and transdermal delivery of chiral drugs. Ph.D. Thesis. Milan, Italy: Universita degli Studi di Milano.
13. Benezra C, Stampf JL, Barbier P, Ducombs G. 1985. Enantiospecificity in allergic contact dermatitis. A review and new results in Frullania-sensitive patients. Contact Dermatitis 13(2):110-114.
14. Papageorgiou, C, Stampf JL, Benezra C. 1988. Allergic contact dermatitis to tulips: An example of enantiospecificity. Arch Dermatol Res 280(1):5-7.
15. Weston, A, Hodgson RM, Hewer AJ, Kuroda R, Grover PL. 1985. Comparative studies of the metabolic activation of chrysene in rodent and human skin. Chem Biol Interact 54(2):223-242.
16. Miyazaki K, Kaiho F, Inagaki A, Dohi M, Hazemoto N, Haga M, Hara H, Kato Y. 1992. Enantiomeric difference in percutaneous penetration of propranolol through rat excised skin. Chem Pharm Bull (Tokyo) 40(4):1075-1076.
17. Millership JS, Collier PS. 1997. Topical administration of racemic ibuprofen. Chirality 9(3):313-316.
18. Touitou E, Chow DC, Lawter JR. 1994. Chiral β-blockers for transdermal delivery. Int J Pharm 104(1):19-28.
19. Suedee R, Brain KR, Heard CM. 1999. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient. Chirality 11(9):680-683.
20. Heard CM, Suedee R. 1996. Stereoselective adsorption and trans-membrane transfer of propranolol enantiomers using cellulose derivatives. Int J Pharm 139(1-2):15-23.
21. Zahir A, Kunta JR, Khan MA, Reddy IK. 1998. Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin. Drug Dev Ind Pharm 24(9):875-878.
22. Ahmed S, Imai T, Otagiri M. 1996. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: Mechanism of stereoselective permeation. Pharm Res 13(10):1524-1529.
23. Adams SS, Bresloff P, Mason CG. 1976. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of the (-)-isomer. J Pharm Pharmacol 28(3):256-257.
24. Dwivedia SK, Sattari S, Jamail F, Mitchell AG. 1992. Ibuprofen racemate and enantiomers: Phase diagram, solubility and thermodynamic studies. Int J Pharm 87(1-3):95-104.
25. Burger A, Koller KT, Schiermeier WM. 1996. RS-ibuprofen and S-ibuprofen (dexibuprofen): Binary system and unusual solubility behaviour. Eur J Pharm Biopharm 42(2):142-147.
26. Romero AJ, Rhodes CT. 1991. Approaches to stereospecific preformulation of ibuprofen. Drug Dev Ind Pharm 17(5):777-792.
27. Leising G, Resel R, Stelzer F, Tasch S, Lanziner A, Hantich G. 1996. Physical aspects of dexibuprofen and racemic ibuprofen. J Clin Pharmacol 36(12 Suppl):3S-6S.
28. Cilurzo F, Alberti E, Minghetti P, Gennari CG, Casiragh A, Montanari L. 2010. Effect of drug chirality on the skin permeability of ibuprofen. Int J Pharm 386(1-2):71-76.
29. Dwivedi SK, Sattairi, S, Jamali, F, Mitchell, AG. 1992. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic of the (-)-isomer. Int J Pharm 87(1-3):95-104. 1992. Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic of the (-)-isomer. Int J Pharm 87(1-3):95-104.
30. Romero AJ, Rhodes CT. 1993. Stereochemical aspects of the molecular pharmaceutics of ibuprofen. J Pharm Pharmacol 45(4):258-262.
31. Leclercq M, Collet A, Jacques J. 1976. Study on mixtures of optical-antipodes-XII. Tetrahedron 32(7):821-828.
32. Collet A, Ziminski, L, Garcia, C. 1995. Chiral discrimination in crystalline enantiomers systems: Fact, interpretations, and speculations. In NATO ASI series-Supramolecular stereochemistry; Siegel JS, Ed. Vol. 91 (91-110). The Netherlands: Kluwer Academic.
33. Yuan X, Capomacchia AC. 2010. Physicochemical studies of binary eutectic of ibuprofen and ketoprofen for enhanced transdermal drug delivery. Drug Dev Ind Pharm 36(10):1168-1176.
34. Yuan X, Capomacchia AC. 2005. The binary eutectic of NSAIDS and two-phase liquid system for enhanced membrane permeation. Pharm Dev Technol 10(1):1-10.
35. Ngawhirunpat T, Panomsuk S, Opanasopit P, Rojanarata T, Hatanaka T. 2006. Comparison of the percutaneous absorption of hydrophilic and lipophilic compounds in shed snake skin and human skin. Pharmazie 61(4):331-335.
36. Priprem A, Khamlert C, Pongjanyakul T, Radapong S, Rittirod T, Chitropas P. 2008. Comparative permeation studies between scale region of shed snake skin and human skin in vitro. Am J Agric Biol Sci 3:444-450.